SCI时时刷

search
PARP1 bound to XRCC2 promotes tumor progression in colorectal cancer
PARP1 bound to XRCC2 promotes tumor progression in colorectal cancer
By complexing poly (ADP-ribose) (PAR) in reaction to broke strand, PAR polymerase1 (PARP1) acts as the key enzyme particip...
Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases
Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases
Lung metastases are the primary cause of death for osteosarcoma (OS) patients. We recently validated interleukin-11 recept...
Repurposing FDA-approved compounds to target JAK2 for colon cancer treatment
Repurposing FDA-approved compounds to target JAK2 for colon cancer treatment
Colorectal cancer is one of the common cancers worldwide and the second leading cause of cancer-related death. The current...
Insights into the prognostic value and immunological role of CD74 in pan-cancer
Insights into the prognostic value and immunological role of CD74 in pan-cancer
CD74 is a non-polymorphic type II transmembrane glycoprotein. It is involved in the regulation of T and B cell development...
Efficacy of immunotherapy in ARID1A-mutant solid tumors: a single-center retrospective study
Efficacy of immunotherapy in ARID1A-mutant solid tumors: a single-center retrospective study
Immune checkpoint inhibitors (ICIs), especially those targeting programmed cell death-1 (PD-1) and programmed cell death l...
A rare case report: multiple intrahepatic masses in a pediatric patient with citrin deficiency
A rare case report: multiple intrahepatic masses in a pediatric patient with citrin deficiency
Deficiency of citrin, the liver-type aspartate-glutamate carrier, arises from biallelic mutations of the gene SLC25A13. Al...
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer
Microfibril-associated protein 2 (MFAP2) is a protein presenting in the extracellular matrix that governs the activity of ...
Advances in the molecular regulation mechanism of tumor dormancy and its therapeutic strategy
Advances in the molecular regulation mechanism of tumor dormancy and its therapeutic strategy
Tumor dormancy is a stage in the growth and development of malignant cells and is one of the biological characteristics of...
A cuproptosis-related signature predicts prognosis and indicates cross-talk with immunocyte in ovarian cancer
A cuproptosis-related signature predicts prognosis and indicates cross-talk with immunocyte in ovarian cancer
Cuproptosis, programmed cell death by intracellular copper-mediated lipoylated protein aggregation, is involved in various...
Longitudinal tracking of circulating rare events in the liquid biopsy of stage III–IV non-small cell lung cancer patients
Longitudinal tracking of circulating rare events in the liquid biopsy of stage III–IV non-small cell lung cancer patients
In the United States, lung cancer is the second most common type of cancer with non-small cell lung cancer (NSCLC) encompa...
circ_WASF2 regulates ferroptosis by miR-634/ GPX4 signaling in pancreatic cancer
circ_WASF2 regulates ferroptosis by miR-634/ GPX4 signaling in pancreatic cancer
Pancreatic cancer (PC) is one of the most lethal malignant gastrointestinal tumors (GI) characterized by a poor prognosis....
The regulation of hypoxia-related lncRNAs in hepatocellular carcinoma
The regulation of hypoxia-related lncRNAs in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is still a public health disease with its high prevalence and morbidity. Short of early dia...
CXCL10 could be a prognostic and immunological biomarker in bladder cancer
CXCL10 could be a prognostic and immunological biomarker in bladder cancer
As proteins that promote immune cell differentiation, chemokines have attracted great interest regarding their role in ant...
Nomogram for predicting survival in T1–T2 stage patients with supraglottic squamous cell carcinoma
Nomogram for predicting survival in T1–T2 stage patients with supraglottic squamous cell carcinoma
Supraglottic squamous cell carcinoma (SGSCC) is characterized by low differentiation, rapid growth, and inconspicuous init...
Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA
Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA
Breast cancer (BC) ranks first among female malignant tumors and involves hormonal changes and genetic as well as environm...